We utilize cookies in order to optimize the website. By navigating further in the site or closing this window, you accept our cookie policy

Print Share

​Cees de Jong will step down as CEO of Chr. Hansen Holding A/S

​Cees de Jong will step down as CEO of Chr. Hansen Holding A/S
Press ReleaseNov 28. 2017 07:03 GMT

Chr. Hansen’s Chief Executive Officer Cees de Jong has informed the Company that after having led Chr. Hansen as CEO for almost 5 years, he intends to pursue a career as a non-executive director outside Chr. Hansen in due course.

The Company has initiated a process to find his replacement, and until then Cees de Jong will continue as CEO of Chr. Hansen.

Ole Andersen, Chairman of the Company’s Board of Directors, says: “Cees has done a tremendous job for Chr. Hansen and its shareholders, employees and other stakeholders. Together with the Corporate Leadership Team, Cees has steered the Company while delivering in accordance with our financial goals, helped develop an ambitious strategy and been a driving force behind our initiatives to pursue new growth opportunities. Chr. Hansen will be in a much stronger shape when Cees leaves, than when he arrived. We have several new and exciting prospects. I therefore look forward to identifying and appointing a new CEO for Chr. Hansen among the very strong candidates there will naturally be for this attractive position.”

Cees de Jong says: “Chr. Hansen has a unique competence base and strong growth prospects, and it is, and has been, a privilege to be the CEO since 2013. The Company and its employees have been creating excellent results and are continuing to deliver on the “Nature’s No. 1” strategy, turning Chr. Hansen into a true global microbial solutions company. While I am choosing now to pursue a different career, I will continue fully dedicated in my role as CEO for Chr. Hansen until my replacement has been found”.


Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2016/17 financial year was EUR 1,063 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.

What are you looking for?

Share this with

Select your preferred language